This inventor holds 4 USPTO granted patents. Top assignees: Wake Forest University, American Home Products Corporation, Other. Active years: 1999-2001.
Company Filing History:
3 out of 524 
2 out of 1,567 
1 out of 834,350 Years Active: 1999-2001
Title: J Mark Cline: Innovator in Atherogenesis Research
Introduction
J Mark Cline is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of medical research, particularly in understanding the effects of certain compounds on cardiovascular health. With a total of 4 patents, his work has implications for both male and female health.
Latest Patents
Cline's latest patents focus on the effects of 17 &agr;-dihydroequilenin on various health parameters. His research presents a method for using this compound to prevent and reduce atherogenesis in both males and females. The findings indicate that 17 &agr;-dihydroequilenin can prevent endothelium-dependent vasoconstriction and improve plasma lipid profiles without causing adverse effects such as endometrial proliferation in females or feminizing changes in males. This innovative approach has the potential to prevent serious health issues like breast and prostatic hyperplasia.
Career Highlights
Throughout his career, Cline has worked with esteemed organizations such as Wake Forest University and American Home Products Corporation. His research has been pivotal in advancing our understanding of cardiovascular health and the role of specific compounds in mitigating risks associated with atherosclerosis.
Collaborations
Cline has collaborated with notable colleagues, including Thomas B Clarkson and Michael R Adams. These partnerships have enriched his research and contributed to the development of his innovative patents.
Conclusion
J Mark Cline's work exemplifies the intersection of innovation and health research. His contributions to understanding the effects of 17 &agr;-dihydroequilenin highlight the importance of continued research in preventing cardiovascular diseases.